Results 331 to 340 of about 1,439,975 (404)

Anti-Oxidized Low-Density Lipoprotein Antibodies Before and After Intravenous Immunoglobulin Therapy in Kawasaki Disease　- Evidence for a Potentially Protective Role. [PDF]

Circ Rep
Kano Z, Mizuno Y, Murata K, Onoyama S, Hoshina T, Sakai Y, Kishimoto J, Kusuhara K, Hara T.   +8 more
europepmc   +1 more source

Chemically Synthesized LRAD3‐D1 Interacts with N‐Terminal Domain of SARS‐CoV‐2 Spike Protein

ChemBioChem, EarlyView.
Chemical synthesis, calcium‐templated in‐vitro folding and competitive ELISA assay reveal that only domain 1 of the LRAD3 ectodomain interacts with the severe acute respiratory syndrome‐related corona virus 2 (SARS‐CoV‐2) spike NTD, while domains 2 and 3 do not, providing valuable insight into ACE2‐independent viral entry pathways that may contribute ...
Mrinmoy Jana, Rathina Delipan, Arighna Sarkar, Sreejith Raran‐Kurussi, Rajesh P. Ringe, Kalyaneswar Mandal   +5 more
wiley   +1 more source

Low-density lipoprotein cholesterol goal attainment and mortality in ischaemic heart disease: a two-year observational study. [PDF]

Singapore Med J
Mak YH, Chua F, Koh XH, Tan VH, Lee ZH, Lam A, Tong KL, Yeo C, Chow W, Loh WJ.   +9 more
europepmc   +1 more source

Reduced Uptake of Oxidized Low-Density Lipoprotein by Macrophages Using Multiple Aptamer Combinations. [PDF]

ACS Appl Bio Mater
Khongwichit S, Swangphon P, Nualla-Ong A, Prompat N, Amatatongchai M, Lieberzeit PA, Chunta S.   +6 more
europepmc   +1 more source

Effect of Low-Density Lipoprotein (LDL) and High-Density Lipoprotein (HDL) on Frozen Gelation of Egg Yolk. [PDF]

Foods
Yuan J, Lin S, Liu K, Guo F, Bao Z.
europepmc   +1 more source

Association between small dense low-density lipoprotein and carotid intima-media thickness. [PDF]

J Cardiovasc Thorac Res
Khosravi M, Sheikhnia F, Pashaei MR, Karimi-Dehkordi M, Alizadeh-Fanalou S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Electronegative low-density lipoprotein

Current Opinion in Lipidology, 2004
The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
Jordi Ordóñez-Llanos, José Luis Sánchez-Quesada, Sonia Benitez   +2 more
openaire   +3 more sources